Welcome to CDC stacks | Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enough - 76933 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Impact of second-line drug resistance on tuberculosis treatment outcomes in the United States: MDR-TB is bad enough
  • Published Date:
    August 03 2012
  • Source:
    Int J Tuberc Lung Dis. 16(10):1331-1334
  • Language:
    English
Filetype[PDF-299.20 KB]


Details:
No Related Documents.
You May Also Like: